wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28070296-295A3815-F0E1-4515-A514-7ACE207900FF
Q28070296-295A3815-F0E1-4515-A514-7ACE207900FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28070296-295A3815-F0E1-4515-A514-7ACE207900FF
Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders
P2860
Q28070296-295A3815-F0E1-4515-A514-7ACE207900FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28070296-295A3815-F0E1-4515-A514-7ACE207900FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
31cca68dbde755556c204edb2726cdb20dc62e69
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.